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s, goal of this study was to aum patients with
-,stage heart d after implantation of a left ventricular
Asslst device at red and during exercise compatible with activities
of deity life.
l nd. Mechanical circulatory assistance with a left
ventricular evice Is an accepted therapy for bridging
patients with end heart d to h transplantation and
has for tong-term implantation .
M . Three patients ( 37, 42 and 57 years) with
end heart failure required implantation of a pneumatically
driven, asynchronous Thermedics left ventricular assist device
while awaiting plantation. All were messed 1 month
later du graded sur1ne bicycle ex (maximal work 1
100 to 150 W). Detailed central y ics, including contin-
uous oxygen saturation and oxygen consump-
tion measurements, were obtained . Two of the patients also
underwent upright treadmill exercise with oxygen consumption
measurements.
Results . During supine bicycle exercise, the heart rate In-
creased 37 beats/min (95' confidence interval: mean*
tt x SE) at rest to 119 * 54 beats/min ad left ventricular
device rate In f rons 82 t 47 to 109 t 55 beats/mIn. Oxygen
comastapiM 1 3.0t0.9to17t2.9ml
Currently, the only available therapy for refractory end-
stage heart failure is heart transplantation. As a result of the
shortage of available donor hearts and an increasing poten-
tial number of recipients, mechanical support devices such
as the left ventricular assist device have been suggested as
future long-term therapeutic alternatives (1,2) . Previous use
of the left ventricular assist device has been limited to
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per kg body weight. Cardiac output Increased from 6.0 t 4.4 to
9.6 ± 7 .1 liters/min, yielding an average exercise factor of 8 .5 ±
7.7 and an exercise Index of 0.83 ± 0.61 .
The patients assessed during treadmill exercise achieved a
maxi oxygen consumption of 14.3 and 16 .7 ml of
oxygen/min
per kg. No th mbollc or other complications attributable to
left ventricular assist device implantation occur during the
duration of support. All patients survived o otopic heart trans-
plantation and are doing well .
Conclusions. Significant work loads compatible with activities
of daily life and adequate exercise hemodyn ics were demon-
strated by these patients while awaiting heart transplantation.
Definitive conclusions i the use of this device must
be viewed as preliminary because only three patients were
involved fn this study and the failure rate may be as high
as 71 (95% confidence interval of left ventricular assist
device success as a bridge to transplantation 29.3% to 100%).
Final conclusions regarding the safety and efficacy of the left
ventricular assist device as a possible long-term circulatory sup-
port device must await results of larger multicenter trials in
(.1 Am Coil C iol 1993,22 .1574-80)
bridging to heart transplantation (2-6) and treatment of acute
cardiogenic shock (7-9) and postcardiotomy low output
states (3,10-13). However, patients being considered for
long-term implantation should also be able to respond ap-
propriately to the varying hemodynamic demands of activi-
ties of daily life over time .
The Thermedics HeartMate 10001P left ventricular assist
device (TC!) functions in a fill to empty mode that allows an
increase in pump rate and output with increasing venous
return. We assessed the ability of the heart-pump complex to
respond physiologically to the increased circulatory de-
mands of supine bicycle and upright treadmill exercise in
three patients awaiting heart transplantation . We also report
a combined Doppler echocardiographic-phonocardiographic
technique for the noninvasive assessment of left ventricular
assist device function in vivo .
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Methods
Patients
Patient 1. This patient is a 57-year old man with a history
of anterior myocardial infarction, two coronary artery by-
pass grafts and a left ventricular aneurysmectomy . Left
ventricular ejection fraction measured by a radionuclide wall
motion study was 24% before an acute lateral myocardial
infarction complicated by refractory cardiogenic shock de-
spite administration of 10 IAg/kg per min of dobutamine,
16 pS/kg per min of dopamine, intraaortic balloon placement
and intubation . Mean right atrial pressure was 15 mm Hg,
pulmonary artery pressure was 50/35 mm Hg and pulmonary
capillary wedge pressure was 30 min Hg with a cardiac index
of 1 .7 liters/min per in" (body surface area 2
.2 m
2) and a
pulmonary vascular resistance of 214 dynes-slem' . He un-
derwent Thermedics left ventricular assist device implanta-
tion and subsequently orthotopic heart transplantation was
performed 7 weeks later . He was discharged 3 weeks after
transplantation .
Patient 2. This patient is a 42-year old man with idio-
pathic cardiomyopathy and a left ventricular ejection frac-
tion of 11% at cardiac catheterization before device implan-
tation. Mean right atrial pressure was 15 mm Hg, pulmonary
artery pressure was 44/30 mm Hg and pulmonary capillary
wedge pressure was 30 mm Hg with a cardiac index of
1 .2 liters/min
per
m2 (body surface area 1 .83 m2) and a
pulmonary vascular resistance of 174 dynes-s/em' . Despite
therapy with 10 pg/kg per min of dobutamine, 4 /ig/kg per
min of dopamine, mechanical ventilation and intraaortic
balloon pump placement, he developed progressive hypoten-
sion and underwent Thermedics left ventricular assist device
implantation. Five months after device placement, the pa-
tient underwent uncomplicated orthotopic heart transplanta-
tion and was discharged 3 weeks later .
Patient 3.
This patient is a 37-year old man with idio-
pathic cardiomyopathy who had a left ventricular ejection
fraction of 10% at cardiac catheterization . He was admitted
with progressive ventricular dysfunction in July 1992, requir-
ing 5 Ag/kg per min of dobutamine, 10 .tg/kg per min of
dopamine, intraaortic balloon placement and intubation
.
Mean right atrial pressure was 19 mm Hg, pulmonary artery
pressure was 48/32 mm Hg, pulmonary capillary wedge
pressure was 25 mm Hg with a cardiac index of 1
.8 liters/min
per m2 (body surface area 2 m
2 ) and a pulmonary vascular
resistance of 267 dyneS
. S/CM5
. He became hypotensive and a
Thermedics left ventricular assist device was implanted,
complicated by postoperative neurologic dysfunction that
resolved over the following week
. Six weeks later, he
underwent orthotopic heart transplantation and was dis-
charged 2 weeks later .
Protocol
The use of the left ventricular assist device in patients
with refractory heart failure awaiting heart transplantation
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was approved by the Sharp Memorial Hospital Investiga-
tional Review Committee. Patients gave written informed
consent for each protocol before testing.
A Thermedics left ventricular assist device was placed
using standard techniques with a left ventricular apical
inflow cannula, a pneumatically powered pump in the upper
peritoneal cavity and an ascending aortic outflow cannula .
Unidirectional flow through the assist device was regulated
by the use of one-way porcine valves . After the patients left
the intensive care unit, an exercise regimen was instituted,
which consisted of upright bicycle and chair exercises, as
well as low level workouts in the gym . There was general
physical improvement over the waiting period . Anticoagu-
lant therapy consisted solely of aspirin (325 mg/day) and
dipyridamole (150 mg/day).
Approximately I month after left ventricular assist device
placement while awaiting heart transplantation, patients
underwent right heart catheterization with continuous oxy-
gen consumption determination at rest and with supine
bicycle exercise. Patients 2 and 3 also had treadmill testing
with oxygen consumption measurements . Doppler echocar-
diography with phonocardiography study was recorded sep-
arately . No left ventricular assist device thrombus was noted
at the time of explantation in any patient .
Hemodynamics during supine bicycle exercise . An 8F
thermodilution Swan-Ganz catheter with a pulmonary artery
tip oximeter (Edwards) was placed through the right internal
jugular vein . The tip oximeter was calibrated in vivo to a
pulmonary artery blood sample oxygen content valve . A left
radial artery line was placed percutaneously for continuous
arterial pressure measurement . Continuous oxygen con-
sumption was measured with 3 ventilatory analyzer (Sensor-
medics System 4400) . Continuous arterial oxygen saturation
was performed with a finger monitor (Oxisensor 24, Nell-
cor) . Supervised supine bicycle exercise was begun at 50-W
power output with a protocol increasing the work load 25 W
every 3 min until fatigue . Throughout exercise, measure-
ments from the control unit of the Thermedics left ventric-
ular assist device were recorded including stroke volume,
left ventricular assist device rate and calculated assist device
output .
Ventilation during treadmill exercise
. Upright treadmill
exercise was performed using a modified Bruce protocol
with increments every 3 mill
. The second stage of this
protocol was equivalent to Bruce stage I
. Oxygen consump-
tion and left ventricular assist device performance were
measured continuously as just described .
Doppler echocardiographic measurements
. Standard
Doppler echocardiographic techniques were performed with
an Acuson 128XP/5 system and a 6-MHz transducer
. After
assessing different locations, phonocardiographic transducer
recordings (Electronics for Medicine; Mission Viejo, Cali-
fornia) were made at the left lower sternal border (that is,
near apex-left ventricular assist device inflow cannula) and
recorded simultaneously with the echocardiogram and elec-
trocardiogram .
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Table 1 . Hemodynamic and Oxygen Consumption Data During Supine Bicycle Exercise
Pressure is represented as systolic/diastolic, mean . Anaerobic threshold was not able to be estimated . Left ventricular assist device (LVAD) output wits
calculated from LVAD rate and stroke volume . % arterial sat - % arterial oxygen saturation ; BP = blood pressure ; CO = cardiac output : Max maximal ;
PA - mean pulmonary artery pressure; % PA sat - % pulmonary artery saturation ; PCW = mean pulmonary capillary wedge pressure, PVR pulmonary
vascular resistance ; RA - mean right atrial pressure ; RER = respiratory exchange rate ; SVR = systemic vascular resistance ; Vco, = carbon dioxide
consumption ; Voi/kg - oxygen consumption.
Group measurements. These are reported as 95% confi-
dence limits : mean ± to.025 x standard error . Failure rates of
the left ventricular assist device were defined by patients not
surviving to heart transplantation . The 95% confidence in-
terval was used to estimate the interval within which the true
failure rate lies (14) .
Results
Hemoillynamle and oxygen consumption me isurcments
during supine bicycle exercise (Table 1, Fig . I to i). Hemo-
dynamic results of the supine bicycle study are shown in
Table 1, Heart rate increased steadily during exercise from
93 ± 37 at rest to 119 :t 54 beatsimin at a maximum 100 and
150 W of power output. Heart rate and left ventricular assist
device rate increased in parallel during exercise (Fig . 1) .
Mean arterial pressure changed from 89 ± 47 to 97 t
43 mm Hg as cardiac output increased from 6 .0 ± 4.4 to
9.6 ± 7.1 literstmin. Left ventricular assist device output
approximated cardiac output at rest, but not at peak exercise
(Fig . 2). Right atria] and pulmonary capillary wedge pres-
sures were normal at rest in two of three patients, but all had
an increase with ext:t6st, Systemic vascular resistance
decreased from 1,068 ± 642 to 693 ± 558 dynes-slem" and
pulmonary vascular resistance decreased from 123 ± 29 to
99 ± 79 dyn"-,*m-I -
Oxygen consumption increased from 3 .0 ± 0.9 to 8 .7
2.9 ml of oxygen/min per kg . Pulmonary artery oxygen
saturation decreased progressively during exercise as arte-
rial
oxygen saturation remained relatively unchanged
Figure 1 . Comparison of heart rate and left ventricular assist device
(VAD) rate during supine bicycle exercise . Heart rate and assist
device rate increased similarly over the exercise period . Maximal
power outputs of 100 W (Patients [Pt .l I and 2) and 150 W (Patient
3) were attained during the last 3 min of exercise .
130 n
-0-Pt
. 1
-Pt . 3
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-0-K I
-0-K 2
-4-Pt
. 3
3 5 7 9 1 1 13 15
Time (min)
Patient I Patient 2 Patient 3
Measured Factor
132scline Max Exercise
Baseline Max Exercise Baseline Max Exercise
Heart rate (beats/min)
76 95
105 126 98 137
LVAD rate (beats/min)
67 86 75
Ito
103 130
BP (mm Hg) 133/60,85 145/79,105
146170, 94 152/78,97 134/70, 88 120159, 80
RA (mm Hg) 12
20 5 8 4 8
PA (mm Hg)
18 31 15 21 16 33
PCW (mm Hg)
12
24 3 7 3 17
Fick CO (liters/min)
4 .3 8 .2 5 .9 7 .8 7 .8 12 .9
LVAD output (liters/min) 5 5 .4
5 .4 7 .1 6 .6 9
.4
PVR (dynes's per cm') III 67
135 131 123
99
SVR (dynes•s per cm') 1,358 819 985 827 861 434
% arterial sat 98 97
98
95
97
94
% PA sat 62 36
73 49 65
35
VoAg (ml 01/min per kg) 2 .6 8.3 3 .0 7,8 3 .3 10 .0
Respiratory rate (breaths/min) 25 33 19
37
21 44
Tidal volume (liters) 0, 52 1 .02 0 .54
0 .69 0,48 1 .10
RER (Vco
.,Noj ) 0,89 1,05 0,86 1 .18 0 .80 1 .28
Peak power output (W) 100 100 150
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14
12
LVAD Fick
Patient 3
Figure 2 . Comparison of left ventricular assist device (LVAD)
output and calculated Fick cardiac output during baseline study
(solid bars) and maximal (Max) supine bicycle exercise (hatched
bars) . L = liters .
(Fig . 3) . Normal values for the exercise factor of 8 .5 ± 7.7
(>600 ml/min cardiac output/100 tail/min oxygen consump-
tion) and exercise index of 0 .97 ± 0.61 (>0.8 real/cardiac
index theoretic) resulted .
Changes in left ventricular assist device function (Fig . 4).
The assist device rate increased steadily from a baseline of
67, 75 and 103 strokes/min to a peak 86, 130 and 110
strokes/min, respectively (Fig . I and 4) . Left ventricular
assist device output also increased from 5.0, 5 .4, and
6.6 liters/min to 6.1, 7 .1 and 9 .4 liters/min, respectively . Left
ventricular assist device stroke volume stayed essentially
constant, with only small variations during exercise .
Changes in hemodynamics and ventilation during treadmill
exercise (Table 2). Treadmill testing was performed in two
patients . Heart rate increased from 112 and 119 beats/min at
baseline to 157 and 156 beats/min at modified Bruce protocol
stage 3 (standard stage 2, Table 2) . Blood pressure changed
from 135190 and 110/60 mm Hg to 125/85 and 130/70 mm Hg
(systolic/diastolic), respectively, at peak exercise . Oxygen
consumption increased from 5 .3 and 4.2 to 16.7 ml oxygen/
min per kg and 14 .3 ml oxygen/min per kg .
Left ventricular assist device physiology as measured by
Doppler phonoechocardiography (Fig . 5). Doppler recording
from the right sternal border window detected left ventricu-
lar assist device output cannula flow and aided in identifica-
tion of the mechanical events corresponding to phono-
graphic sounds. The left ventricular assist device phonogram
consisted of three distinct sounds (V1, V2, Vp)
(Fig . 5),
corresponding, respectively, to onset of assist device ejec-
tion consistent with inflow cannula valve closure, cessation
of assist device ejection consistent with outflow cannula
valve closure and a lower frequency sound preceding the end
of assist device ejection consistent with assist device dia-
phragm end-excursion as the pusher plate is stopped by the
stroke limiter. These acoustic markers were used in assess-
ment of assist device filling .
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Figure 3. Comparison of oxygen uptake (VO,) (top panel), arterial
oxygen
(02)
saturation (center panel) and pulmonary artery oxygen
saturation (bottom panel) during supine bicycle exercise . Pt .
patient.
When operating in an asynchronous fill to empty mode,
the left ventricular assist device begins ejection when filling
achieves a full chamber volume. Thus, the left ventricular
and left ventricular assist device rates differ in general and
will vary phasically relative to each other . When assist
device filling coincides with left ventricular diastole (syn-
chrony), inflow velocity occurs with an M-shaped patt ,~rn,
where the first peak represents rapid early diastolic inflow
and the second represents either transmitted atrial kick or
early ventricular contraction .
When assist device filling
coincides with left ventricular systole (countersynchrony),
inflow exhibits a single, higher velocity peak. The duration
of assist device filling (V 2 to V,) was shorter with counter-
synchronous than with synchronous timing (360 vs . 400 ms) .
Wit, the left ventricular assist device functioning, left
ventriciiar size was smaller and systolic wall motion ap-
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-0-Pt.
I
-0--Pt, 2
--0-43
Poltre 4. Comparison of left ventricular assist device hemodynam-
ics during supine bicycle exercise . Assist device rate (top panel) and
flow
(Imoom pulel) both increased during exercise . Assist device
stroke volume (SV) (center Panel) remained relatively unchanged.
Abbreviations as in Figures 1 and 3 .
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Figure 6. Determination of in vivo left ventricular assist device
function with combined Doppler echocardiography and phonocar-
diography, showing the electrocardiogram (EKG) assist device
phonograin and assist device inflow velocity . Doppler flow study
showed both synchronous (S) and near countersynchronous (CS)
filling from the left ventricle into the assist device. Phonogram V,
represented inflow valve closure, V2 outflow valve closure and V
P
the stopping of the assist device diaphragm before end-ejection . The
duration of countersynchronous assist device Oiling (V, io V,) was
shorter than that during synchrony (360 vs . 400 ms) .
peared significantly improved compared with echocardio-
graphic assessment before device implantation . Minimal to
no aortic valve opening was present at rest but was consis-
tently noted during exercise .
Use of left ventricular assist device as a bridge to trans-
plantation . Because only three patients were studied in this
series, the potential rate of failure is high, with a 95%
confidence interval of assist device success as a bridge to
transplantation from 29.3% to 10017o (14) .
Discussion
We believe that this is the first clinical report of left
ventricular assist device-assisted hemodynamics during ex-
ercise. The heart-left ventricular assist device complex re-
Table 2. Hemodynamic and Oxygen Consumption Data During Treadmill Exercise
Maximal exercise was achieved at the end of modified Bruce protocol stage 3 (standard stage 2) . Threshold
V0,A9 at anaerobic threshold ; other abbreviations as in Table 1 .
Patient 2 Patient 3
Measured Factor Baseline Max Exercise Baseline Max Exercise
Heart rate (beatstmin) 112 157 119 156
Systolic HP (mm Hg) 135 125 Ito 130
Diastolic BP (mm Hg) 90 85 60 70
V,41 (ml Qmin per kg) 5 .3 16.7 4.2 14 .3
Respiratory rate (breaths/min) 19 54 21 47
Tidal volume (liters) 0.64 1 .30 0.62 1 .80
RER (0y'vo
.)02NO" 0
.91 1 .50 013 131
Threshold Od Gynin per kg)
15
-
12.1
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sponded physiologically and demonstrated a significant cir-
culatory reserve consistent with the capability of meeting
demands of simple daily activities .
Previous studies involving the application of the left
ventricular assist device have considered determinants of
immediate circulatory sufficiency after implantation, the
ability to wean patients after cardiotomy or the use as a
bridge to cardiac transplantation . Pae et al . (5) suggested the
need for long-term assist device capability for those awaiting
heart transplantation, and other investigators (1,2,4) have
suggested permanent implantation as an alternative to trans-
plantation. In a preliminary report, Murali et al . (15) re-
ported that patients in New York Heart Association class It'
heart failure before device implantation had increased oxy-
gen consumption during treadmill exercise similar to those
with class III heart failure . However, central hemodynamics
were not asseised .
Similar to findings in patients without heart disease (16),
oxygen consumption increased more with treadmill than
with supine bicycle exercise . Peak oxygen consumption was
below that of normal persons (16 .7 and 14.3 vs. 28 to 43 ml
oxygen/min per kg, respectively) but was comparable to that
in patients approximately 3 months after orthotopic heart
transplantation (mean ± SD 17 .5 ± 0.9 ml oxygen/min per kg
[17]) . In addition, blood pressure response to exercise was
blunted. Because our patients were studied only I month
after implantation, further increases in oxygen consumption
as reported by Muralli et -1 .
(15)
may have be?n achieved
with additional physical training .
For our patients, both the computed exercise factor and
the exercise index value indicated a normal (or near normal
for Patient 1) cardiac output response to the increased
oxygen demands of exercise (18). Because the Thermedics
left ventricular assist device operates on an asynchronous fill
to empty mode, it can increase cardiac output by increasing
rate with increased venous return . Left ventricular assist
device stroke volume is set and remains essentially constant
(Fig. 3), much as in normal hearts, where stroke volume
changes only slightly to achieve the increased cardiac output
during vigorous exercise (19) . Thus, the heart-pump com-
plex responds physiologically to exercise and may be suit-
able to meet the physical demands of daily life .
Most if not all of the systemic cardiac output at rest is
contributed by the left ventricular assist device . Thus,
although the device is placed in parallel to the native left
ventricle, it effectively functions as a series pump for the
systemic circulation . Doppler echocardiography in our pa-
tients showed minimal to no aortic valve opening or left
ventricular outflow tract ejection at rest . During exercise,
however, aortic ejection was apparent by echocardiography
and total systemic output exceeded assist device output .
This suggests that with exercise, the parallel contribution of
left ventricular ejection contributes to the heart assist device
complex reserve .
JASKI ET AL
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Thrombosis after left ventricular assist device implanta-
tion . In general, thrombogenesis after left ventricular assist
device implantation is a major concern (3,6,9,13)
. However,
assist devices that have recently become available, including
the Thermedics left ventricular assist device, have been
shown clinically to have a low incidence of thrombogenesis
(2,6,20,21). Graham et al . (20) and McGee et al . (21) noted
that the texturized surfaces of the left ventricular assist
device blood-contacting chamber become coated with a
cellular coagulum, presumably collagen, fibrin, fibroblasts
and myofibroblasts. We attribute the decreased incidence of
thrombosis in our patients to 1) these textured surfaces as
compared with smooth-surfaced assist devices using higher
dose antithrombotic regimens (6,13), 2) the use of porcine
rather than mechanical valves, and 3) an internal hemody-
namic design that minimizes blood stasis . The complete
filling and emptying of the left ventricular assist device when
it is operating in an asynchronous mode would also decrease
blood stasis, Other contributing factors may be the occa-
sional opening of the aortic valve and the increased wall
motion of the contracting left ventricle .
Although the ideal antithrombotic therapy with the left
ventricular assist device is not known, our center and others
have found the use of aspirin and dipyridamole to be
adequate for minimizing thrombosis . Only 2% of all patients
with a Thermedics left ventricular assist device have had
thrombotic complications (Thermedics, Inc., personal com-
munication) compared with higher incidence rates with the
use of other left ventricular assist devices (6,13) . The benefit
of stronger anticoagulant therapies is unclear but may be
salutary for antithrombosis as well as the prophylaxis of the
heart in the chronically supported patient .
Concerns with long-term left ventricular assist device im-
plantation . For a left ventricular assist device to function
not only as a short-term bridge to transplantation but as a
long-term heterotopic assist device, some minimal function
of both the right and the left heart chambers as well as a limit
to elevated pulmonary vascular resistance may be required .
Sato et al . (22) suggested that left ventricular assist device
support may aggravate right heart failure in patients with a
dysfunctional right ventricle, and the right heart has been
implicated in other studies (4,10,13) as a limiting factor in left
ventricular assist device success . In our patients, the right
ventricular echocardiogram and pulmonary vascular resis-
tance measured before implantation suggested that the left
ventricular assist device would be adequate for bridging to
transplantation. Left ventricular device assistance decreased
right ventricular afterload by decreasing pulmonary capillary
wedge pressure and pulmonary artery impedance after im-
plantation and was associated with improved right heart
function. However, the degree of right heart dysfunction and
elevated pulmonary vascular resistance that would be a
contraindication to long-term left ventricular assist device
implantation is uncertain .
Because the left ventricle aids in left ventricular assist
device filling, preservation or potential recovery of left
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ventricular function may assist in the reduction of right
ventricular afterload. Although right ventricular function
may be a primary factor influencing perioperative survival,
residual left ventricular function may be a more important
determinant of circulatory reserve with activity after opera-
tive recovery. Ideally, hemodynamic criteria before implan-
tation (that is, right and left ventricular function and revers-
ibly elevated pulmonary vascular resistance) for determining
the suitability of a patient for long-term left ventricular assist
device assistance should be established. This is beyond the
scope of this report but is an important area of future
research .
An ideal left ventricular assist device for long-term use
would be totally implanted without pneumatic or electrical
lines penetrating the skin barrier, and two such devices are
currently under investigation (23,24) . Our device would not
be adequate for permanent implantation because of the size
of the console that drives the device . In a preliminary report
(25), a portable, vented, electric left ventricular assist device
similar to the KeartMate has been used successfully with
long-term implantation for > 1 year. Nevertheless, the he-
modynamic criteria for any left ventricular assist device
functioning during exercise are likely to be similar .
Conclusions. Definitive conclusions regarding the use of
this device must be viewed as preliminary because only
three patients were involved in this study and the potential
failure rate is high, Final conclusions regarding the safety
and efficacy of the left ventricular assist device as a possible
long-term circulatory support device must await results of
larger multicenter trials now in progress .
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